Last reviewed · How we verify
NCT04156971
Effects of Omega-3 Supplementation on Nutritional Status and Physical Activity of Obese Children
NA trial testing Omega 3 in Life Style Modification in 37 participants. Completed in 28 February 2015.
31 July 2014
Quick facts
| Lead sponsor | Universiti Putra Malaysia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 37 |
| Start date | 1 June 2013 |
| Primary completion | 31 July 2014 |
| Estimated completion | 28 February 2015 |
Drugs / interventions tested
- Omega 3 — full drug profile →
- stage-based lifestyle modification intervention
Conditions studied
- Life Style Modification — all drugs for Life Style Modification →
- Childhood Obesity — all drugs for Childhood Obesity →
Sponsor
Universiti Putra Malaysia — full company profile →
Who can join
Adults 7 to 11, any sex, with Life Style Modification or Childhood Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Omega-3 Long-Chain Polyunsaturated Fatty Acids has potential as a supplement that can accelerate the effects of a weight management program in children. This study assessed the effects of fish oil supplementation on biochemical profile, body composition, diet and physical activity of obese children. A total of 37 obese children (7-11 years) were randomized to intervention (n=19) or control (n=18) group. Data were collected at baseline, at follow-up (every four weeks) and at 24 of the interventions. The intervention group (IG) received stage-based lifestyle modification intervention and fish oil supplement, while the control group (CG) received stage-based lifestyle modification intervention only. Changes in biochemical profile, body composition, diet and physical activity were examined in both intervention and control groups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04156971
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Omega 3
Trials testing the same drug.
- NCT05774665 — Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression · Phase 2 · active not recruiting
- NCT06555705 — Effect of Omega 3 Supplementation on the Heart Rate Variability in Obese Children · NA · completed
- NCT07138131 — Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia · NA · completed
- NCT06463535 — Effects of Omega-3 as an Adjunct to Non-Surgical Periodontal Therapy on Chemerin Level in Periodontitis Patients With Di · NA · completed
- NCT04411615 — Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery · NA · unknown
Other Universiti Putra Malaysia trials
Trials by the same sponsor.
- NCT07365787 — Internet-Based Group CBT for Anxiety and Depression Among International Students · NA · not yet recruiting
- NCT07325760 — Effectiveness of a ReMIND Diet Intervention on Sarcopenia, Cognitive Frailty and Nutritional Status in Older Adults · NA · not yet recruiting
- NCT07139561 — A Digital Intervention to Improve Oral Health Practices · NA · not yet recruiting
- NCT07095595 — The Effect of Education-based Patient Safety on Nursing Leaders' and Educators' Perceptions of Patient Safety Culture in · NA · active not recruiting
- NCT07115433 — Effectiveness of School-based Oral Health Intervention for Children · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04156971 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universiti Putra Malaysia
- Last refreshed: 13 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04156971.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing